RN Mobile Menu

Search form




Psoriasis (©Artemidapsy/Shutterstock.com)

Axial disease seems to increasingly depend on the presence of skin psoriasis and HLA-B*27 alleles, researchers write in ARD.

Psoriasis (©Hriana/Shutterstock.com)

New treatment guidelines for plaque psoriasis have been issued in the U.S. where 50 percent of patients say they are dissatisfied with treatment.

Up to 30% of psoriasis patients will develop psoriatic arthritis. Studies show that a proportion of patients in clinical care have undiagnosed PsA.

Researchers reporting at the American Society of Hematology annual meeting this week say there is a link between a treatment for autoimmune disease and the development of leukemia.

Researchers find that apremilast and CF101 both are safe and effective for psoriasis, but apremilast outperforms CF101 through 16 weeks, until it plateaus.

Safety results from studies of rheumatoid arthritis patients are not fully applicable to psoriasis patients, recent studies show.


Patients with moderate-to-severe psoriasis who switch biologic medications at the end of a clinical trial should go through an induction period.


Subscribe to Psoriasis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.